Overview
Stock Quote
Presentations
SEC Filings
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
» View Pipeline
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Drug Discovery
» Overview
» Conditions
» Intellectual Property
» Research
» R&D Pipeline
» Cobroxin
» Nyloxin
Medical Devices
» Overview
» Conditions
» Intellectual Property
» Research
Newsroom
» Recent News
» Archives
» E-Alerts
Investor Relations
» Overview
» Stock Quote
» Presentations
» SEC Filings
Corporate Overview
» Overview
» Management Team
» Board of Directors
» Social Responsiblity
» NPC Blog
» Presentations
» Code of Ethics
Contact
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Stock Quote
Stock Symbol:
NPHC
Exchange:
OTCBB
Last Trade:
0.16
*
Change:
0.00
Volume:
42826
*Quote delayed 20 minutes.
Stock Charts
5-Day Chart
6-Month Chart
1-Year Chart
Select a Destination
Drug Discovery
Medical Devices
Newsroom
Investor Relations
Corporate Overview
August 19, 2010
Nutra Pharma Begins Drug Registration Process in India for Nyloxin - a Treatment for Moderate to Severe Chronic Pain
August 09, 2010
Nutra Pharma Announces Amarey Nova Medical as its Exclusive Nyloxin Distributor in Colombia
August 06, 2010
Nutra Pharma Announces Second Quarter 2010 Sales and Distribution Update
Click here
to learn more about Nyloxin, our over-the-counter treatment for moderate to severe chronic pain.
Privacy Policy
|
Code of Ethics
Copyright © 2000-
2010
, Nutra Pharma Corporation. All Rights Reserved.
